Early research (Phase 1)WithdrawnNCT05940844
What this trial is testing
Study of OB-002 in Patients With Refractory Metastatic Cancer
Who this might be right for
Metastatic CancerMetastatic Colorectal CancerMetastatic Pancreatic Cancer+3 more
Orion Biotechnology Polska Sp. z o.o.